PhaseV Raises $15M for ML-Driven Clinical Trial Optimization
What You Should Know: PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has raised $15 million in funding, led by Viola Ventures and…
Continue Reading